Table 1.
Number of subjects | Vaccine 4532 |
Placebo 2267 |
---|---|---|
Delhi | 2532 | 1267 |
Pune | 1000 | 500 |
Vellore | 1000 | 500 |
Age in weeks at dosing, Mean (SD) | ||
Dose 1 | 6·8 (0·6) | 6·8 (0·6) |
Dose 2 | 11·7 (2·4) | 11·7 (2·4) |
Dose 3 | 16·3 (2·8) | 16·4 (2·8) |
Gender, n (%) | ||
Males | 2330 (51·4) | 1157 (51·0) |
Subjects who received each dose, n (%) | ||
Dose 1 | 4532 (100·0) | 2267 (100·0) |
Dose 2 | 4409 (97·3) | 2221 (98·0) |
Dose 3 | 4356 (96·1) | 2190 (96·6) |